Breast Parenchymal Enhancement as a Predictor of Efficacy for Endocrine Therapy

Affiliations

¹ From the Department of Diagnostic Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-ku, Osaka 553-0003, Japan (M.H.); Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (M.H., M.I.); and Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan (M.I.).

Editorial

Maya Honda et al. Radiology. 2023 May.

. 2023 May;307(4):e230350.

doi: 10.1148/radiol.230350. Epub 2023 Mar 28.

¹ From the Department of Diagnostic Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-ku, Osaka 553-0003, Japan (M.H.); Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (M.H., M.I.); and Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan (M.I.).

No abstract available

Comment on

Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study.
Ragusi MAA, van der Velden BHM, Meeuwis C, Tetteroo E, Coerkamp EG, van Nijnatten TJA, Jansen FH, Wolters-van der Ben EJM, Jongen L, van Raamt F, Dorrius MD, Verloop J, Viergever MA, Pijnappel RM, Elias SG, Gilhuijs KGA. Ragusi MAA, et al. Radiology. 2023 May;307(4):e221922. doi: 10.1148/radiol.221922. Epub 2023 Mar 28. Radiology. 2023. PMID: 36975820